Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study

1330–1335 38. Vigil L, Campo C, Segura J et al. Fasting plasma glucose predicts the development of renal insufficiency in essential hypertensive patients with metabolic syndrome. J Hypertens 2003; 21 [Suppl 4]: S16 (abstract) 39. Coresh J, Astor BC, Green T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1–12 40. De Jong PE, Hillege HL, Pinto-Sietsma SJ, De Zeeuw D. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? Nephrol Dial Transplant 2003; 18: 10–13 41. Guyton AC, Coleman TG, Cowley AW Jr, Scheel KW, Manning RD, Norman RA. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation in hypertension. Am J Med 1972; 52: 584–594 42. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348: 101–108 43. Ruilope LM, Lahera V, Rodicio JL, Romero JC. Are renal hemodynamics a key factor in the development and maintenance of hypertension? Hypertension 1994; 23: 3–9 44. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 2002; 346: 913–923 45. Strazzullo P, Galletti F, Barba G. Altered renal handling of sodium in human hypertension. Short review of the evidence. Hypertension 2003; 41: 1000–1005 46. Wright JT Jr, Bakris G, Greene T et al., for the AfricanAmerican Study of Kidney Disease and Hypertension Study Group. J Am Med Assoc 2002; 288: 2421–2431 47. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggresive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002; 61: 1086–1097 48. Schrier RW, McFann K, Johnson A et al. Cardiac and renal effects of standard versus rigorous blood pressure control in autosoma-dominant polycystic kidney disease: results of a seven-year prospective randomized study. J Am Soc Nephrol 2002; 13: 1733–1739 49. Segura J, Campo C, Rodicio JL, Ruilope LM. ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis. Hypertension 2001; 38 [Part 2]: 645–649 50. Nakao N, Yoshimura A, Morita H, Takada M, Kavano T, Ideura T. Combination treatment of angiotensin II-receptor blocker and angiotensin-converting enzyme inhibitor in nondiabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 2003; 361: 117–124